Israel Englander’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Sell
19,610
-115,478
-85% -$601K ﹤0.01% 5450
2026
Q1
$628K Sell
135,088
-168,194
-55% -$963K ﹤0.01% 4654
2025
Q4
$2.36M Sell
303,282
-397,613
-57% -$3.4M ﹤0.01% 3792
2025
Q3
$5.85M Sell
700,895
-295,146
-30% -$2.49M ﹤0.01% 2977
2025
Q2
$7.07M Buy
996,041
+487,355
+96% +$3.63M ﹤0.01% 2623
2025
Q1
$4.45M Buy
508,686
+299,094
+143% +$3.15M ﹤0.01% 2984
2024
Q4
$2.65M Sell
209,592
-66,065
-24% -$796K ﹤0.01% 3403
2024
Q3
$3.09M Buy
275,657
+199,797
+263% +$2.34M ﹤0.01% 3273
2024
Q2
$973K Buy
75,860
+18,594
+32% +$284K ﹤0.01% 4128
2024
Q1
$895K Sell
57,266
-19,192
-25% -$303K ﹤0.01% 4391
2023
Q4
$1.26M Sell
76,458
-15,669
-17% -$218K ﹤0.01% 3969
2023
Q3
$1.11M Buy
92,127
+80,307
+679% +$1.08M ﹤0.01% 4105
2023
Q2
$168K Sell
11,820
-100,546
-89% -$1.47M ﹤0.01% 5183
2023
Q1
$1.74M Sell
112,366
-345,720
-75% -$5.6M ﹤0.01% 3572
2022
Q4
$7.99M Buy
458,086
+434,005
+1,802% +$6.45M ﹤0.01% 2376
2022
Q3
$307K Buy
24,081
+7,938
+49% +$106K ﹤0.01% 5337
2022
Q2
$183K Sell
16,143
-97,312
-86% -$924K ﹤0.01% 5680
2022
Q1
$1.18M Buy
+113,455
New +$1.54M ﹤0.01% 4376
2021
Q4
Sell
-23,829
Closed -$341K 6726
2021
Q3
$341K Sell
23,829
-45,559
-66% -$651K ﹤0.01% 5718
2021
Q2
$1.09M Sell
69,388
-34,106
-33% -$548K ﹤0.01% 4586
2021
Q1
$1.73M Sell
103,494
-33,977
-25% -$555K ﹤0.01% 3666
2020
Q4
$2.11M Buy
137,471
+121,809
+778% +$1.79M ﹤0.01% 3194
2020
Q3
$200 Sell
15,662
-15,652
-50% -$202K ﹤0.01% 4067
2020
Q2
$448K Buy
+31,314
New +$458K ﹤0.01% 3465
2020
Q1
Sell
-45,061
Closed -$972K 3797
2019
Q4
$972K Buy
45,061
+16,050
+55% +$329K ﹤0.01% 3020
2019
Q3
$567K Buy
+29,011
New +$533K ﹤0.01% 3182
2018
Q4
Sell
-68,550
Closed -$1.4M 3712
2018
Q3
$1.4M Sell
68,550
-160,359
-70% -$3.35M ﹤0.01% 2672
2018
Q2
$4.54M Buy
+228,909
New +$4.23M 0.01% 1878
2017
Q4
Sell
-592,588
Closed -$10.2M 3764
2017
Q3
$10.2M Buy
592,588
+65,363
+12% +$1.21M 0.02% 1229
2017
Q2
$9.15M Buy
527,225
+400,445
+316% +$7.11M 0.02% 1111
2017
Q1
$2.39M Buy
126,780
+75,380
+147% +$1.59M ﹤0.01% 1904
2016
Q4
$1.16M Sell
51,400
-183,375
-78% -$4.01M ﹤0.01% 2163
2016
Q3
$4.32M Sell
234,775
-128,555
-35% -$2.31M 0.01% 1425
2016
Q2
$5.98M Buy
363,330
+103,440
+40% +$1.66M 0.01% 1150
2016
Q1
$4.11M Sell
259,890
-403,461
-61% -$5.84M 0.01% 1365
2015
Q4
$9.35M Sell
663,351
-347,700
-34% -$5.34M 0.02% 960
2015
Q3
$14.6M Buy
1,011,051
+207,539
+26% +$3.37M 0.03% 719
2015
Q2
$13.4M Buy
803,512
+455,968
+131% +$10.8M 0.03% 812
2015
Q1
$8.41M Sell
347,544
-205,702
-37% -$5.23M 0.02% 1118
2014
Q4
$13.6M Buy
553,246
+268,556
+94% +$6.25M 0.03% 808
2014
Q3
$6.29M Sell
284,690
-90,889
-24% -$2.14M 0.02% 1148
2014
Q2
$10.3M Buy
375,579
+61,337
+20% +$1.78M 0.03% 807
2014
Q1
$9.75M Buy
314,242
+311,142
+10,037% +$8.59M 0.03% 821
2013
Q4
$76K Sell
3,100
-7,800
-72% -$163K ﹤0.01% 3358
2013
Q3
$198K Sell
10,900
-55,647
-84% -$1.27M ﹤0.01% 3109
2013
Q2
$1.59M Buy
+66,547
New +$1.61M ﹤0.01% 1731

Other funds holding OSG

Israel Englander's OSG Position: Q2 2026 in Review

Israel Englander reduced its Octave Specialty Group (OSG) stake by 85% in Q2 2026, selling an estimated $601K and leaving 19,610 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #5450.

Israel Englander first reported a position in OSG in Q2 2013 and has held it in 46 quarters since. The position peaked at $14.6M in Q3 2015. 147 funds tracked by Wall St. Rank hold OSG as of Q2 2026.

  • Israel Englander held 19,610 shares of Octave Specialty Group worth $122K as of Q2 2026.
  • Israel Englander sold 115,478 Octave Specialty Group shares in Q2 2026, an estimated $601K.
  • Octave Specialty Group made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5450 holding.
  • Israel Englander first reported a position in Octave Specialty Group in Q2 2013 and has held it in 46 quarters since.
  • Israel Englander's Octave Specialty Group position peaked at $14.6M in Q3 2015.
  • 147 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.